PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL - the ZEISS AT LUCIA toric 721P
Launching at ESCRS in London, the world's first bitoric hydrophobic monofocal intraocular lens with a non-constant asphericity profile design expands the ZEISS LUCIA Family to treat cataracts while simultaneously ...
2026-09-10T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection
— Phase IIb multicenter trial initiated, bringing this potential life-changing therapy closer to patients — ...
2026-09-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
SINGAPORE , Sept. 10, 2026 /PRNewswire/ -- Novo Holdings, a leading global healthcare and life sciences investor, today announced a strategic minority investment in Huizhou ForYou Medical Devices ...
2026-09-10T    Banking/Financial Service   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
/C O R R E C T I O N -- CordenPharma/
In the news release, CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year, issued 10-Sep-2026 by CordenPharma over PR Newswire, we are advised by the company ...
2026-09-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dymax Launches BlueWave® FX Line Emitters to Boost Throughput in High-Speed Linear UV/Visible Curing
- New 75 mm and 150 mm line emitters deliver up to 4.2 W/cm² with 365/385/405 nm options and FX controller compatibility for scalable automation. ...
2026-09-10T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health
SHENZHEN, China , Sept. 9, 2026 /PRNewswire/ -- Commemorating BGI Group's 27th anniversary, BGI Genomics today introduced its Digital Life Twin framework alongside an advanced multi-omics diagnostic ...
2026-09-09T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast
SEOUL, South Korea , Sept. 9, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma, has launched " Robert's YUniverse " , a new podcast series featuring conversations with guests ...
2026-09-09T    Biotechnology   Medical/Pharmaceuticals 
First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA
BEIJING and BRIDGEWATER, Mass. , Sept. 9, 2026 /PRNewswire/ -- Gan&Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan&Lee) announced that the first participant has been dosed in a ...
2026-09-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Clinical Psychologist Urges Women to Recognise the Signs of a Dysregulated Nervous System
MELBOURNE, Australia , Sept. 9, 2026 /PRNewswire/ -- Women are becoming increasingly skilled at functioning while struggling, says Clinical Psychologist Dr Jennifer Menon, who is urging women to ...
2026-09-09T    Health Care/Hospital   Medical/Pharmaceuticals 
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [22⁵Ac]Ac-FL-261 Phase 1 Clinical Trial
LONDON , Sept. 9, 2026 /PRNewswire/ -- Full-Life Technologies ("Full-Life", the "Company") , a privately held, fully integrated, clinical-stage actinium-based global radiopharmaceutical ...
2026-09-09T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.